Prudential Financial’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4,973
| Closed | -$50.5K | – | 2340 |
|
2024
Q4 | $50.5K | Hold |
4,973
| – | – | ﹤0.01% | 2209 |
|
2024
Q3 | $61.9K | Buy |
+4,973
| New | +$61.9K | ﹤0.01% | 2622 |
|
2024
Q2 | – | Sell |
-1,308
| Closed | -$29.6K | – | 2749 |
|
2024
Q1 | $29.6K | Sell |
1,308
-346
| -21% | -$7.84K | ﹤0.01% | 2633 |
|
2023
Q4 | $21.5K | Buy |
1,654
+360
| +28% | +$4.67K | ﹤0.01% | 2612 |
|
2023
Q3 | $26K | Buy |
+1,294
| New | +$26K | ﹤0.01% | 2558 |
|
2023
Q1 | – | Sell |
-920
| Closed | -$46.9K | – | 2634 |
|
2022
Q4 | $46.9K | Sell |
920
-1,193
| -56% | -$60.8K | ﹤0.01% | 2495 |
|
2022
Q3 | $173K | Sell |
2,113
-1,320
| -38% | -$108K | ﹤0.01% | 2470 |
|
2022
Q2 | $232K | Buy |
+3,433
| New | +$232K | ﹤0.01% | 2423 |
|
2019
Q2 | – | Sell |
-5,902
| Closed | -$517K | – | 2472 |
|
2019
Q1 | $517K | Buy |
5,902
+1,000
| +20% | +$87.6K | ﹤0.01% | 2077 |
|
2018
Q4 | $689K | Buy |
4,902
+3,434
| +234% | +$483K | ﹤0.01% | 1924 |
|
2018
Q3 | $375K | Sell |
1,468
-32
| -2% | -$8.17K | ﹤0.01% | 2122 |
|
2018
Q2 | $382K | Sell |
1,500
-3,082
| -67% | -$785K | ﹤0.01% | 2115 |
|
2018
Q1 | $923K | Buy |
4,582
+3,307
| +259% | +$666K | ﹤0.01% | 1874 |
|
2017
Q4 | $184K | Buy |
+1,275
| New | +$184K | ﹤0.01% | 2270 |
|